| abstract |
The present disclosure describes methods of using peptidomimetic macrocycles in combination with adjunctive therapy to treat conditions such as cancer. In some embodiments, the peptidomimetic macrocycle can alleviate the side effects of the add-on therapy (eg, mucositis, neutropenia, or thrombocytopenia). |